Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-trace').style.display = (document.getElementById('cakeErr6805a195498f1-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6805a195498f1-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-code').style.display = (document.getElementById('cakeErr6805a195498f1-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-context').style.display = (document.getElementById('cakeErr6805a195498f1-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6805a195498f1-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6805a195498f1-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 15968,
		&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16096,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 15968,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;patents,Health,free trade agreement&#039;,
	&#039;metaDesc&#039; =&gt; &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 15968,
	&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16096,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 15968
$metaTitle = &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;
$metaKeywords = &#039;patents,Health,free trade agreement&#039;
$metaDesc = &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal | Im4change.org</title>
    <meta name="description" content="



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act also targets non-profits</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>European Commission's next move</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-trace').style.display = (document.getElementById('cakeErr6805a195498f1-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6805a195498f1-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-code').style.display = (document.getElementById('cakeErr6805a195498f1-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-context').style.display = (document.getElementById('cakeErr6805a195498f1-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6805a195498f1-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6805a195498f1-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 15968,
		&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16096,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 15968,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;patents,Health,free trade agreement&#039;,
	&#039;metaDesc&#039; =&gt; &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 15968,
	&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16096,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 15968
$metaTitle = &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;
$metaKeywords = &#039;patents,Health,free trade agreement&#039;
$metaDesc = &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal | Im4change.org</title>
    <meta name="description" content="



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act also targets non-profits</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>European Commission's next move</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-trace').style.display = (document.getElementById('cakeErr6805a195498f1-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6805a195498f1-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-code').style.display = (document.getElementById('cakeErr6805a195498f1-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6805a195498f1-context').style.display = (document.getElementById('cakeErr6805a195498f1-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6805a195498f1-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6805a195498f1-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 15968,
		&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16096,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 15968,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;patents,Health,free trade agreement&#039;,
	&#039;metaDesc&#039; =&gt; &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 15968,
	&#039;title&#039; =&gt; &#039;European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Act also targets non-profits&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16096,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 15968
$metaTitle = &#039;LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal&#039;
$metaKeywords = &#039;patents,Health,free trade agreement&#039;
$metaDesc = &#039;



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The Act&#039;s dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;These organisations have been objecting to the definition of &amp;ldquo;counterfeit&amp;rdquo; in the Act. &amp;nbsp;&amp;ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&amp;rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Act also targets non-profits&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &amp;nbsp;The European Parliament&#039;s ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &amp;ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&amp;rdquo; added Rehman.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;European Commission&#039;s next move&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &amp;ldquo;We will consult with our international partners on how to move forward with the issue,&amp;rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal | Im4change.org</title>
    <meta name="description" content="



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act also targets non-profits</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>European Commission's next move</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 15968,
		'title' => 'European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>Act also targets non-profits</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>European Commission's next move</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
</div>',
		'credit_writer' => 'Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 16096,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 15968,
	'metaTitle' => 'LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal',
	'metaKeywords' => 'patents,Health,free trade agreement',
	'metaDesc' => '



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...',
	'disp' => '<div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act also targets non-profits</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>European Commission's next move</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 15968,
	'title' => 'European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>Act also targets non-profits</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>European Commission's next move</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.
</div>',
	'credit_writer' => 'Down to Earth, 5 July, 2012, http://www.downtoearth.org.in/content/european-parliament-rejects-anti-counterfeiting-trade-agreement',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'european-parliament-rejects-anti-counterfeiting-trade-agreement-ankur-paliwal-16096',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 16096,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 15968
$metaTitle = 'LATEST NEWS UPDATES | European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal'
$metaKeywords = 'patents,Health,free trade agreement'
$metaDesc = '



Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries





It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement...'
$disp = '<div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">These organisations have been objecting to the definition of &ldquo;counterfeit&rdquo; in the Act. &nbsp;&ldquo;It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,&rdquo; said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Act also targets non-profits</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines. &nbsp;The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. &ldquo;The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,&rdquo; added Rehman.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>European Commission's next move</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. &ldquo;We will consult with our international partners on how to move forward with the issue,&rdquo; said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

European Parliament rejects Anti-Counterfeiting Trade Agreement-Ankur Paliwal

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines. ACTA, primarily drafted and secretly negotiated by the US, was signed on October 1, last year by eight countries, including Australia, Canada and the United States. To get it ratified in the European Union, its executive body, the European Commission, put the draft in the European Parliament for its approval, where it got the thumbs down. The Act's dismissal was glad tidings for humanitarian and medical organisations that have been opposing it because it gives powers to enforcement agencies like the customs departments to seize products that are counterfeit or infringe Intellectual Property Rights (IPR) during transit or in the importing country. These organisations have been objecting to the definition of “counterfeit” in the Act.  “It is so loosely drafted that even legitimately produced generic medicines could be termed as counterfeit and seized and detained, hindering access for people who rely on these medicines to survive,” said Aziz ur Rehman, IP advisor to Medicins Sans Frontieres (MSF), an international medical humanitarian organisation. Act also targets non-profits ACTA is so designed that a mere complaint by patent holding companies that a particular consignment is counterfeit is enough for the customs department of a country to seize and destroy the medicines.  The European Parliament's ruling is particularly important for India because it is seen as the drug pharmacy of the developing world; it exports generic medicines to many developing countries. “The way ACTA is written, it would have given an unfair advantage to patented medicines, and restricted access to affordable generic medicines to the detriment of patients and treatment providers,” added Rehman. The stringent provision in ACTA would have also targeted third parties, including non-governmental organisations, distributing these generic medicines to people in developing countries where patents have not been granted to drugs. Since 2008, many consignments of standard generic drugs which were legitimately produced in India were seized at the ports of Paris and Netherlands on the complaints by the patent-holder companies which claimed the products were counterfeit. European Commission's next move However, the European Commission, the executive body of the EU, which has been pushing for ACTA, is unperturbed by the vote. “We will consult with our international partners on how to move forward with the issue,” said Karel de Gucht , EU trade commissioner. European Commission became signatory to ACTA this January.